Matches in Nanopublications for { ?s ?p ?o <http://www.tkuhn.ch/bel2nanopub/RApsq5K5bPO8JfC2bktmKJfONjO8fAGluVHfIK5zU52GY#provenance>. }
Showing items 1 to 11 of
11
with 100 items per page.
- _4 label "Selventa" provenance.
- large_corpus.bel title "BEL Framework Large Corpus Document" provenance.
- large_corpus.bel description "Approximately 61,000 statements." provenance.
- large_corpus.bel version "20131211" provenance.
- large_corpus.bel authoredBy _4 provenance.
- assertion wasDerivedFrom large_corpus.bel provenance.
- assertion wasDerivedFrom _3 provenance.
- assertion hadPrimarySource 17463250 provenance.
- _3 wasQuotedFrom 17463250 provenance.
- _3 value "In the parental cell line, EGFR, ERBB3, ERBB2, and METwere all phosphorylated, and this phosphorylation was either completely or markedly reduced upon gefitinib treatment.The phospho-specific EGFR (pY1068), MET (pY1234/1235), ERK1/2 (pT185/pY187) antibodies were purchased from Invitrogen (Carlsbad, CA)." provenance.
- large_corpus.bel rights "Copyright (c) 2011-2012, Selventa. All rights reserved." provenance.